Skip to content
OpenCapital
Get started

Dermata Therapeutics, Inc. DRMA Q1 2026 earnings

Reported May 13, 2026 · Before market open

Diluted EPS-$0.48Beat by $0.05
EPS estimate-$0.53

Next report

Aug 18, 2026 (in a month)
EPS estimate-$0.55

Versus estimates

Diluted EPS

Q1 2026-$0.48Beat by $0.05
Q4 2025-$1.52Beat by $0.02Q3 2025-$1.65Miss by $0.06Q2 2025-$1.66Beat by $1.24Q1 2025-$4.50Miss by $4.05Q4 2024-$3.15Miss by $1.65

Ask the moment Dermata Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Dermata Therapeutics, Inc. report Q1 2026 earnings?
Dermata Therapeutics, Inc. (DRMA) reported Q1 2026 earnings on May 13, 2026 before market open.
What were Dermata Therapeutics, Inc.'s Q1 2026 revenue and EPS?
Dermata Therapeutics, Inc. reported diluted EPS of $-0.48 for Q1 2026.
Did Dermata Therapeutics, Inc. beat estimates in Q1 2026?
EPS beat the consensus estimate of $-0.53 by $0.05.
How did Dermata Therapeutics, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS grew 89.3% from $-4.50.
Where can I find Dermata Therapeutics, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-022710) and the 10-Q periodic report (0001493152-26-022719) directly on SEC EDGAR. The filing index links above go to sec.gov.